Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission. Issue 6 (10th April 2018)

• Record Type: Journal Article
• Authors: Noguchi, Yusuke; Tomizawa, Daisuke; Hiroki, Haruka; Miyamoto, Satoshi; Tezuka, Mari; Miyawaki, Reiji; Tanaka‐Kubota, Mari; Okano, Tubasa; Kobayashi, Chika; Mitsuiki, Noriko; Aoki, Yuki; Imai, Kohsuke; Kajiwara, Michiko; Kanegane, Hirokazu; Morio, Tomohiro; Takagi, Masatoshi
• Is Part Of: Clinical case reports. Volume 6:Issue 6(2018)
• Page Start: 1023
• Page End: 1028
• Publication Date: 2018-04-10
• Subjects: Hematopoietic cell transplantation -- L‐Asparaginase -- myeloid/natural killer cell precursor acute leukemia; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.1506
• Languages: English
• ISSNs: 2050-0904

Abstract

Key Clinical Message: Myeloid/natural killer cell precursor acute leukemia (MNKPL) is a rare leukemia subtype characterized by a high incidence of extramedullary infiltration. No appropriate treatment strategy has so far been developed. Acute myelogenous leukemia‐type chemotherapy combined with L‐Asparaginase is an effective treatment for MNKPL. Hematopoietic cell transplantation is a second option in refractory cases. Abstract : Myeloid/natural killer cell precursor acute leukemia (MNKPL) is a rare leukemia subtype characterized by a high incidence of extramedullary infiltration. No appropriate treatment strategy has so far been developed. Acute myelogenous leukemia‐type chemotherapy combined with L‐Asparaginase is an effective treatment for MNKPL. Hematopoietic cell transplantation is a second option in refractory cases.